Side-by-side financials for ELAB and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ELAB | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #45 |
| Revenue (latest FY) | $590.08K | - |
| Net income (latest FY) | -$7.75M | - |
| Net margin | -1313.0% | - |
| SEC filings | 252 | 1,002 |
Full pages: Elevai Labs Inc. and AstraZeneca PLC, or browse the full rankings.